Combinatorial Compositions And Methods Of Treating Hemoglobinopathies

Abstract

Provided herein are compositions and methods for increasing fetal hemoglobin expression (HbF) for the treatment and/or amelioration of the symptoms of a hemoglobinpathy in a mammal. The compositions comprise a combination of one or more inhibitors of BCL11A expression or activity with epigenetic modifers, such as inhibitors of DNA methylation and/or one or more inhibitors of histone deacetylases.


Claims

Download Citation


Sign in to the Lens

Feedback